The Technion, the Rambam Medical Center and the Medical University of South Carolina will collaborate on stem cell research

In this collaboration, American and Israeli scientists will expand the possibility of funding from the American Health Organization and accelerate the development of treatment methods that will be registered as a patent and implemented into commercial products

The Technion, the Rambam Medical Center and the Medical University of South Carolina will collaborate on stem cell research. The President of the American University, Professor Ray Greenberg and Professor Rafi Biar, Director of the Rambam Medical Center, signed a Memorandum of Understanding for the continuation of the cooperation between the Medical University and the Technion and Rambam. "Imagine a day when doctors will be able to use a patient's skin cells to revive old hearts, grow a new heart valve or restore a heart suffering from rhythm problems without the need for a pacemaker. This day is closer than you imagine", they said at the signing ceremony.

Scientists and researchers from around the world gathered in the new Bioengineering Building at the Medical University of South Carolina (MUSC) to mark the first international conference on cardiovascular tissue regeneration. The conference marks the beginning of a broad and long-term research collaboration between scientists in Israel and the US, the goal of which is to promote scientific breakthroughs in stem cell research. Some of the innovations that the collaboration will focus on are:

- Creation of new tissues of skin, muscle and other organs, which will replace the damaged tissues.

- Restoring the normal heart rate without the need for a mechanical pacemaker.

- Replacement of tissues damaged by a heart attack.

- Repairing weakened arteries, and preventing aneurysms.

In this collaboration, American and Israeli scientists will expand the possibility of funding from the American Health Organization and accelerate the development of treatment methods that will be registered as a patent and implemented into commercial products. In accordance with the terms of the partnership, there will be bilateral information sharing through visiting professors, sabbatical years and applications for joint grants, joint study programs, joint research projects and an annual conference where the findings will be presented and examined.